MedTrace Logo

Ultra Low Iodine Loaded Spectral CT Angiography (CTA)

NCT05488899 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 216

Last updated 2022-08-05

No results posted yet for this study

Summary

The objectives of this study are:

Evaluation of ultra-low iodine load CTA protocols of the aorta and lower extremities.

To investigate whether dual-layer in combination with with virtual monoenergetic imaging (VMI) allows for reduction of contrast medium (CM) in CTA of the aorta and lower limbs i with sustained objective and subjective image quality parameters.

Conditions

  • Peripheral Arterial Disease
  • Renal Insufficiency

Interventions

DIAGNOSTIC_TEST

Half iodine Spectral CT

Patients receive half dosage of iodine contrast agent, and Spectral CT acquisition with Virtual Monoenergetic Images at 40 and 50 keV.

DIAGNOSTIC_TEST

Standard iodine conventional CT

Patients receive standard dosage of iodine contrast agent, and conventional 120 kv Polychromatic CT acquisition.

Sponsors & Collaborators

  • Oslo Metropolitan University

    collaborator OTHER

  • University Hospital, Akershus

    lead OTHER

Principal Investigators

  • Peter M Lauritzen, MD PhD · University Hospital, Akershus & Oslo University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-28
Primary Completion
2020-10-16
Completion
2020-10-16

Countries

  • Norway

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05488899 on ClinicalTrials.gov